Herbalife (HLF) is back in focus after Q4 2025 earnings showed higher net sales alongside lower quarterly profit, while a fresh tie up with Cristiano Ronaldo around its Pro2col platform grabbed investor attention. See our latest analysis for Herbalife. Investors appear to be reassessing Herbalife’s prospects after the Q4 2025 results and the Cristiano Ronaldo Pro2col partnership, with a 1 day share price return of 3.76% and a 90 day share price return of 71.58% contrasted against a 5 year…